Editor's Essential Reading ➡️ Integrating Evidence to Guide Use of Biologics and Small Molecules for Inflammatory Bowel Diseases ow.ly/VN3C50QHi3X

Now in AJG - The American Journal of Gastroenterology: Our post-hoc analysis from SEAVUE finds CD patients who will have delayed clinical response to biologic therapy often have biomarker improvements observed during the first few weeks of treatment John K. Marshall MD Vipul Jairath MBChB DPhil Parambir Dulai (link in comments)

This is an amazing group. Having personally trained at DMCH for medical school, excited to see the growth and opportunities for training in IBD!

Calling all healthcare professionals! Nominate a colleague for the prestigious Sherman Prize and advance IBD care. Submit nominations at ShermanPrize.org #ShermanPrize #IBD #crohnsandcolitis #crohnsdisease #crohns #ulcerativecolitis #colitis

Trends of inflammatory bowel disease from the Global Burden of Disease Study (1990-2019) Out now in IBD issue Indian Journal of Gastroenterology #DrDharni Dr Vandana Midha Arshdeep Singh #DrAjitSood Parambir Dulai link.springer.com/article/10.100…

#Colonoscopy has long been the gold standard for #ColonCancer screening, with the added benefit of removing polyps before they become cancer. In 60 seconds, Harold J. Boutte Jr., MD, explains the options for at-home colon cancer screening kits. #NMBetter

Team SAIA/IBDesis would like to wish a Happy Sikh New Year to everyone observing 🙏🏽 Sumit Bhatia Kanwarpreet Tandon Manreet Kaur Arshdeep Singh Vishal Sharma Parakkal Deepak MD, MS, FACG Neilanjan Nandi, MD, FACP Gursimran Kochhar MD Parambir Dulai AsianWomenMeanBusiness Chronically Brown

Hit the target? Our latest paper in CGH finds achieving MM-SES-CD <22.5 and SES-CD <4 in Crohn's disease is associated with low risk of disease progression and is a suitable target in clinical trials and practice for endoscopic healing. doi.org/10.1016/j.cgh.…

Here in #Maribor in #Slovenia, we l 💕 use and study 📚 CDST for #Crohns #disease a lot Parambir Dulai the father of #CDSAT #IBD

Amazing trip to Korea for @imkasid2024 Thank you for the wonderful hospitality and discussions!

We're looking forward to welcoming Parambir Dulai NM Gastroenterology & GI Surgery on clinical trials for hospitalized UC flares at this week's Duke GI grand rounds. This is sure to be a good one! @MathewKappus @annaVeerappan #UlcerativeColitis #GITwitter #GIGrandRounds

The recipients of the Sherman Emerging Leader Prize from 2016 to 2023 showcase the qualities of dedication, innovation, and a commitment to the field of IBD. Who should join this remarkable group? Nominate Now! #IBD #crohns #colitis

Very excited to be hosting Jun and looking forward to a thoughtful discussion!

Check out our new thought provoking study🔥🔥 Do 💉have different effect for distal vs extensive UC. TOFA & IFX better for extensive UC>distal. eClinicalMedicine – The Lancet Discovery Science The Lancet Vipul Jairath MBChB DPhil Parambir Dulai Neeraj Narula Laurent Peyrin-Biroulet Christopher Ma MD MPH thelancet.com/journals/eclin…

Great data for PRO endpoints for ASUC.

Adaptive #steroid #tapering impedes corticosteroid-free remissions compared to forced tapering in clinical trials of #UC Neeraj Narula Parambir Dulai Vipul Jairath MBChB DPhil academic.oup.com/ecco-jcc/advan…

Aline Charabaty, MD, FACG, AGAF Beatriz Gros Antonio Caballero Mateos PhD #MondayNightIBD AbbVie JanssenUS ignacio catalan Ashkan Rezazadeh MD Angus Worthing MD Ethan Craig B. Evana Ghassemi, PHARMD, BCACP, BCPS David Choi, PharmD Jason Schairer Puja Mehta 🧩 🌻 Sophie Restellini Joseph Sleiman, MD Jose Manuel Benítez Sandra Kim MD Antonia Churchhouse GETECCU Tauseef Ali MD, FACG AGAF FACP | 🐆 Reezwana C, MD, FACG Joanna Melia Zachary Borman MD Agree with this somewhat. I think fc 150 may be too generous! Here are some data Parambir Dulai led in producing on this: For patients with UC achieving RBS 0 + SFS 0/1, FC ≤ 50 μg/g may avoid endoscopy in 50% patients with a FN rate <5% pubmed.ncbi.nlm.nih.gov/32384283/

Join us for an exciting day of #IBD learning. -> Stellar faculty -> All pertinent clinical topics -> Fellowship Grants available Register at: cme.ahn.org/content/6th-an… Parambir Dulai Dr Feza Remzi Aline Charabaty, MD, FACG, AGAF Edward Barnes MD MPH Kelly Issokson MS RD (she/her) Alimentiv #brianfegan Francis (Frank) Farraye, MD, MSc Phillip Fleshner MD

Fantastic turnout and a wonderful morning session headlined by the stellar Aline Charabaty, MD, FACG, AGAF, Parambir Dulai and Kelly Issokson MS RD (she/her) and Dr Frank Farraye at AHN Gastroenterology, Hepatology and Nutrition's IBD Summit.